3 insiders reported 10 Form 4 transactions for AbCellera Biologics Inc. (ABCL) over the past 18 months (most recent 2026-06-03). Recent activity: Booth Andrew (Chief Financial Officer) Buy 250,000 shares, Montalbano John S. (Director) Buy 20,000 shares, Thermopylae Holdings Ltd. (Insider) Buy 38,000 shares, Booth Andrew (Chief Financial Officer) Buy 42,600 shares, Thermopylae Holdings Ltd. (Insider) Buy 177,457 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-03 | Booth Andrew | Chief Financial Officer | Buy | 250,000 | $47,500 |
| 2026-05-18 | Montalbano John S. | Director | Buy | 20,000 | $95,400 |
| 2026-03-02 | Thermopylae Holdings Ltd. | Insider | Buy | 38,000 | $130,720 |
| 2026-02-27 | Booth Andrew | Chief Financial Officer | Buy | 42,600 | $145,692 |
| 2026-02-27 | Thermopylae Holdings Ltd. | Insider | Buy | 177,457 | $580,284 |
| 2025-12-19 | Thermopylae Holdings Ltd. | Insider | Sell | 225,000 | $0 |
| 2025-11-26 | Montalbano John S. | Director | Buy | 50,000 | $178,500 |
| 2025-03-11 | Thermopylae Holdings Ltd. | Insider | Buy | 343,631 | $742,243 |
| 2025-03-10 | Montalbano John S. | Director | Buy | 25,000 | $57,500 |
| 2025-03-07 | Montalbano John S. | Director | Buy | 60,000 | $140,400 |
Source: SEC Form 4 filings · as of 2026-06-03